Slingshot members are tracking this event:

PDUFA Date for F/TAF for Treatment of HIV set for April 7, 2016

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks


Additional Information

Additional Relevant Details The PDUFA date for Gilead's is April 7, 2016.  If approved, it will join four other single tablet regimens already approved for treatment of HIV developed by Gilead.
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords F/taf, Emtricitabine, Tenofovir Alafenamide, Hiv, Pdufa